Brief: Nova Eye Medical Announces U.S. Market Clearance Of Itrack Advance Canaloplasty Device
12/04/2023 14:09
April 12 (Reuters) - Nova Eye Medical Ltd EYE.AX :
* NOVA EYE MEDICAL ANNOUNCES U.S. MARKET CLEARANCE OF THE
ITRACK™
ADVANCE CANALOPLASTY DEVICE
* NOVA EYE MEDICAL LTD - HAS BEEN GRANTED U.S. FOOD AND DRUG
ADMINISTRATION 510(K) CLEARANCE FOR ITS NEW CANALOPLASTY DEVICE,
ITRACK™ ADVANCE
Source text for Eikon: ID:nBw5j3ZXma
Further company coverage: EYE.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nova Eye Medical
See all newsAustralia's Nova Eye Medical jumps on upbeat FY27 earnings guidance
Brief: Nova Eye Medical Reports FY26 Sales Of $23.7 Million
Australia's Nova Eye Medical soars on FY26 sales forecast upgrade
Brief: Nova Eye Medical Upgrades Fy26 Sales Guidance (Ex-China) To $22–23 Million
Australia's Nova Eye Medical rises on EU approval for glaucoma treatment